Effects of Helicobacter infection on developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Holtzman rats

Lab Animal

Volumn 37, Issue 4, 2008, Pages 171-175

  Kransler, Kevin M ^a   McGarrigle, Barbara P ^a   Russell, Robert J ^b   Olson, James R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Harlan Sprague Dawley Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 1A1; TERATOGENIC AGENT;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FEMALE; FETUS DEATH; FETUS DEVELOPMENT; HELICOBACTER; HELICOBACTER INFECTION; LIVER; LIVER MICROSOME; LONGEVITY; MICROBIOLOGY; NEWBORN; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RAT; SPRAGUE DAWLEY RAT;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANIMALS, NEWBORN; CYTOCHROME P-450 CYP1A1; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; FEMALE; FETAL DEATH; FETAL DEVELOPMENT; HELICOBACTER; HELICOBACTER INFECTIONS; LIVER; LONGEVITY; MICROSOMES, LIVER; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RATS; RATS, SPRAGUE-DAWLEY; TERATOGENS; TETRACHLORODIBENZODIOXIN;

ANIMALIA; HELICOBACTER; RATTUS;

EID: 41149159080     PISSN: 00937355     EISSN: 15484475     Source Type: Journal    
DOI: 10.1038/laban0408-171     Document Type: Article

References (34)

1. Mandal, P.K. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. [B] 175, 221-230 (2005).
2. Birnbaum, L.S. Developmental effects of dioxins. Environ. Health Perspect. 103 Suppl 7, 89-94 (1995).
3. Boverhof, D.R. et al. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci. 94, 398-416 (2006).
4. Hanlon, P.R. et al. Identification of novel TCDD-regulated genes by microarray analysis. Toxicol. Appl. Pharmacol. 202, 215-228 (2005).
5. Ovando, B.J., Vezina, C.M., McGarrigle, B.P. & Olson, J.R. Hepatic gene downregulation following acute and subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 94, 428-438 (2006).
6. Tijet, N. et al. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independentgene batteries. Mol. Pharmacol 69, 140-153 (2006).
7. Vezina, C.M., Walker, N.J. & Olson, J.R. Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression. Environ. Health Perspect. 112, 1636-1644 (2004).
8. Birnbaum, L.S. & Tuomisto, J. Non-carcinogenic effects of TCDD in animals. Food Addit. Contam. 17, 275-288 (2000).
9. National Toxicology Program. Toxicology and Carcinogenesis Studies of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in Female Harlan Sprague-Dawley Rats (Gavage Studies). Technical Report 521, 4-232 (National Toxicology Program, Research Triangle Park, 2006).
10. Marshall, B.J. & Warren, J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315 (1984).
11. Fox, J.G. The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 50, 273-283 (2002).
12. Garcia, A., Xu, S., Dewhirst, F.E., Nambiar, P.R. & Fox, J.G. Enterohepatic Helicobacter species isolated from the ileum, liver and colon of a baboon with pancreatic islet amyloidosis. J. Med. Microbiol. 55, 1591-1595 (2006).
13. Kusters, J.G., van Vliet, A.H. & Kuipers, E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19, 449-490 (2006).
14. Ward, J.M. et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. 86, 1222-1227 (1994).
15. Zenner, L. Pathology, diagnosis and epidemiology of the rodent Helicobacter infection. Comp. Immunol. Microbiol. Infect. Dis. 22, 41-61 (1999).
16. Solnick, J.V. & Schauer, D.B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin. Microbiol. Rev. 14, 59-97 (2001).
17. Solnick, J.V. Clinical significance of Helicobacter species other than Helicobacter pylori. Clin. Infect. Dis. 36, 349-354 (2003).
18. Kanbay, M., Kanbay, A. & Boyacioglu, S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir. Med. 101, 203-209 (2006).
19. Wu, X.Z. & Chen, D. Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrected? J. Gastroenterol. Hepatol. 21, 345-347 (2006).
20. Hailey, J.R. et al. Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol. Pathol. 26, 602-611 (1998).
21. Kransler, K.M., McGarrigle, B.P. & Olson, J.R. Comparative developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the hamster, rat and guinea pig. Toxicology 229, 214-225 (2007).
22. Peterson, R.E., Theobald, H.M. & Kimmel, G.L. Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons. Crit. Rev. Toxicol. 23, 283-335 (1993).
23. Kransler, K.M., Tonucci, D.A., McGarrigle, B.P., Napoli, J.L. & Olson, J.R. Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters retinoid homeostasis in maternal and perinatal tissues of the Holtzman rat. Toxicol. Appl. Pharmacol. 224, 29-38 (2007).
24. Whitlock, J.P. Jr. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39, 103-125 (1999).
25. Greig, J.B. & De Mattel's, F. Effects of 2,3,7,8-tetrachlorodibenzo- p-dioxin on drug metabolism and hepatic microsomes of rats and mice. Environ. Health Perspect. 5, 211-219 (1973).
26. Hill, M. UNSW Embryology (Version 6.1), An educational resource for learning concepts in embryological development. 2007. http://embryology.med. unsw.edu.au/embryo.htm
27. Drahushuk, A.T. et al. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicol. Appl. Pharmacol. 140, 393-403 (1996).
28. Omura, T. & Sato, R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378 (1964).
29. Prough, R.A., Burke, M.D. & Mayer, R.T. Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol. 52, 372-377 (1978).
30. Zenner, L. Pathology, diagnosis and epidemiology of the rodent Weh'coiorten'nfection. Comp. Immunol. Microbiol. Infect. Dis. 22, 41-61 (1999).
31. Whary, M.T. & Fox, J.G. Detection, eradication, and research implications of Helicobacter infections in laboratory rodents. Lab Anim. (NY) 35, 25-27, 30-36 (2006).
32. O'Rourke, J.L. & Lee, A. Animal models of Helicobacter pylori infection and disease. Microbes Infect. 5, 741-748 (2003).
33. Kodama, M. et al. Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis. World J. Gastroenterol. 11, 7063-7071 (2005).
34. Gonciarz, M., Wloch, M. & Gonciarz, Z. Helicobacter pylori in liver diseases. J. Physiol. Pharmacol. 57 Suppl 3, 155-161 (2006).